The independent source for health policy research, polling, and news.
Ńī¹óåś“«Ć½Ņīl Health Newsā coverage related to aging and improving care of older adults is supported in part by .
281 - 300 of 890 Results
For older people, the pandemic is as taxing and worrisome as ever. Experts in geriatric care, mental health, social services, and infectious disease joined a KHN-Hartford Foundation panel to talk about a third covid winter and its outsize toll on seniors.
Twelve years ago, Marna Clarke was seized by a desire to examine what she looked like at age 70 ā and to document the results. This creative project has sustained and engaged her since.
Private Medicare Advantage health plans are increasingly ending coverage for skilled nursing or rehab services before medical providers think patients are healthy enough to go home, doctors and patient advocates say.
Four Seasons Health Care collapsed after years of private equity investors rolling in one after another to buy its business, sell its real estate, and at times wrest multimillion-dollar profits from it through complex debt schemes. The deal-making failed to account for the true cost of senior care.
Investors are banking on increased demand in death care services as 73 million baby boomers near the end of their lives.
Doctors are divided on whether blanket testing of breast cancer patients is warranted, since scientists and physicians are sometimes unsure about how to interpret the results.
Californians were far less likely to die from covid in the first seven months of 2022 than during the first two years of the pandemic. Still, the virus remained among the stateās leading causes of death in July, outpacing diabetes, accidental death, and a host of debilitating diseases. We break down whoās at risk.
Two studies published this year provide evidence that older adultsā cognitive health may benefit if air quality is improved.
As private equity groups are swarming into aging Americaās eye care, the consolidation is costing the U.S. health care system and patients more money.
With prices of necessities rising dramatically, many older Americans are having trouble making ends meet. They often donāt know that help is available from a variety of programs, and some sources of financial assistance are underused.
In this episode, Julie Rovner, chief Washington correspondent for KHN, guides listeners through decades of dealings between Congress and Big Pharma.
A federal judge in Texas issued a decision this week that affects the Affordable Care Act. It says one way that preventive services are selected for no-cost coverage is unconstitutional.
Three women explain how lifeās surprises can catapult their efforts to carefully manage limited budgets and lead to financial distress.
Why is it so hard to agree when life begins? As state abortion laws define it, science, politics, and religion are clashing. KHNās Sarah Varney shared her reporting with the āScience Fridayā radio program.
A two-year congressional investigation has identified troubling lapses in the nationās organ transplant system. Blood types mismatched, diseased organs transplanted anyway, and ā most often ā organs lost or damaged before they can save a life.
The omicron variant has proved adept at finding hosts, often by reinfecting people who recovered from earlier bouts of covid. But whether omicron triggers long covid as often and severe as previous variants is a matter of heated study.
Inflation hasnāt hit Americans like this in decades. And families living with chronic diseases have little choice but to pay more for the medicine, supplies, and food they need to stay healthy.
In pursuit of unpaid bills, nursing homes across Rochester, New York, have been suing relatives and friends of their residents. This CBS News report, done in partnership with a KHN-NPR investigation, takes a look at the practice and tells the stories of some of the people affected.
Under the Medicare drug negotiations provisions in the reconciliation bill, the federal government would see its outlays reduced by about $300 billion. That reduction wouldnāt result from cuts in benefits. Instead, Medicare would be empowered to leverage its market power to pay lower prices for certain drugs.
Ā© 2026 KFF